Details
Title
Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma
Author
Goel, Utkarsh 1 ; Charalampous, Charalampos 1 ; Kapoor, Prashant 1
; Binder, Moritz 1
; Buadi, Francis K. 1
; Dingli, David 1
; Dispenzieri, Angela 1
; Fonder, Amie 1 ; Gertz, Morie A. 1
; Gonsalves, Wilson I. 1 ; Hayman, Suzanne R. 1 ; Hobbs, Miriam A. 1 ; Hwa, Yi L. 1 ; Kourelis, Taxiarchis 1
; Lacy, Martha Q. 1 ; Leung, Nelson 1 ; Lin, Yi 1
; Warsame, Rahma M. 1 ; Kyle, Robert A. 1 ; Rajkumar, S. Vincent 1
; Kumar, Shaji K. 1
1 Mayo Clinic, Division of Hematology, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X)
; Binder, Moritz 1
; Buadi, Francis K. 1
; Dingli, David 1
; Dispenzieri, Angela 1
; Fonder, Amie 1 ; Gertz, Morie A. 1
; Gonsalves, Wilson I. 1 ; Hayman, Suzanne R. 1 ; Hobbs, Miriam A. 1 ; Hwa, Yi L. 1 ; Kourelis, Taxiarchis 1
; Lacy, Martha Q. 1 ; Leung, Nelson 1 ; Lin, Yi 1
; Warsame, Rahma M. 1 ; Kyle, Robert A. 1 ; Rajkumar, S. Vincent 1
; Kumar, Shaji K. 1
1 Mayo Clinic, Division of Hematology, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X)
Pages
11
Publication year
2023
Publication date
Dec 2023
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2764016542
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.